for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer says could apply for U.S. emergency use approval for vaccine in late November

Oct 16 (Reuters) - Pfizer Inc said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany’s BioNTech SE as soon as a safety milestone is achieved in the third week of November. (Reporting by Manojna Maddipatla in Bengaluru Editing by Saumyadeb Chakrabarty)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up